UK Markets closed

Allarity Therapeutics A/S (ALLR.ST)

Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
0.9295+0.0270 (+2.99%)
At close: 5:29PM CEST
Full screen
Previous close0.9025
Open0.9160
Bid0.9290 x N/A
Ask0.9300 x N/A
Day's range0.8915 - 0.9350
52-week range0.6134 - 2.1475
Volume4,571,869
Avg. volume3,547,199
Market cap224.736M
Beta (5Y monthly)0.63
PE ratio (TTM)N/A
EPS (TTM)-0.2680
Earnings date28 Aug 2020
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Allarity Therapeutics Issues Share Units as Payment-In-Kind for Services Rendered During Rights Issue in Q2 2021

    Issuance of share Units fullfils payment obligations to guarantors and coordinator/bookrunner of Rights Issue conducted in Q2 2021 Press release Hørsholm, Denmark (14 July 2021) Allarity Therapeutics A/S (“Allarity” or the “Company”) today announced a payment-in-kind and a debt conversion structured as a directed issue of 24,112,523 new share Units to the guarantors and to the global coordinator and bookrunner, Aalto Capital AB, of the rights issue completed on 11 June 2021 (the “Rights Issue”).

  • Globe Newswire

    Allarity Therapeutics Receives Acceptance & Review Notification from U.S. FDA for Pre-Market Approval Application for Dovitinib-DRP®

    Administrative acceptance review notification of pre-market approval (PMA) application is first step in multi-step process conducted by the FDAThe PMA is submitted in support of an imminent new drug application (NDA) for dovitinib Press release Hørsholm, Denmark (5 July 2021) — Allarity Therapeutics A/S (“Allarity” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has provided a positive administrative acceptance and review notification for the Company's PMA appl

  • Globe Newswire

    Last day of trading with Allarity Therapeutics A/S BTU

    Press release Hørsholm, Denmark (24 June 2021) – Allarity Therapeutics A/S (“Allarity”) today announced that the recently completed Rights Issue, announced on 10 June 2021, has now been registered with the Danish Business Authority. The last day of trading with Allarity Therapeutics A/S BTU (Paid Subscribed Unit) is 30 June 2021. The stop date, whereafter the conversion of the BTUs into shares and warrants will take place, is on 2 July 2021. The new shares and warrants ALLR TO 3 are expected to